[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345405-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345405-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prevalence-of-high-risk-human-papillomavirus-genotypes-and-associated-hiv-co-infection-in-cameroon-a-systematic-review-and-meta-analysis","Prevalence of high-risk human papillomavirus genotypes and associated HIV co-infection in Cameroon - a systematic review and meta-analysis","","High-risk human papillomavirus (HR HPV) infection drives cervical cancer, and Cameroon faces evidence gaps that limit prevention planning. This study synthesizes national data on HR HPV prevalence, genotype distribution, and HIV co-infection among HPV-positive individuals. Systematic review and meta-analysis followed PRISMA guidelines, registered in PROSPERO, and pooled prevalence using random-effects models, assessing heterogeneity via I² and subgroup analyses, with study quality judged by JBI tools.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prevalence-of-high-risk-human-papillomavirus-genotypes-and-associated-hiv-co-infection-in-cameroon-a-systematic-review-and-meta-analysis/345405/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prevalence-of-high-risk-human-papillomavirus-genotypes-and-associated-hiv-co-infection-in-cameroon-a-systematic-review-and-meta-analysis/345405.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study objective in Cameroon?","Question",{"text":63,"@type":64},"To synthesize national evidence on HR HPV prevalence, genotype distribution, and HIV co-infection among HPV-positive individuals in Cameroon.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies selected and analyses conducted?",{"text":68,"@type":64},"The review followed PRISMA, was registered in PROSPERO, searched multiple databases, included studies reporting HR HPV prevalence among sexually active individuals, and used random-effects models with I² heterogeneity and subgroup analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings on HR HPV prevalence and genotype patterns?",{"text":72,"@type":64},"The overall pooled HR HPV prevalence was 28.95%, with higher values in women with precancerous/cancerous lesions and female sex workers. Predominant genotypes included HPV16, HPV52, HPV66, HPV33, and HPV18.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345405,1790096785,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Cheuyem etal. Infectious Agents and Cancer (2026) 21:43 Infectious Agents and Cancer  \n[https://doi.org/10.1186/s13027-026-00756-5](https://doi.org/10.1186/s13027-026-00756-5)  \nRESEARCH Open Access  \nPrevalence of high-risk human papillomavirus  genotypes and associated HIV co-infection in Cameroon: a systematic review and metaanalysis  \nFabrice Zobel Lekeumo Cheuyem1,2*, Chabeja Achangwa3, Lionel Berthold Keubou Boukeng4,5,  \nRick Tchamani6, Alapa Junior Nkwate Chefor7, Jessy Goupeyou-Youmsi8 and Edmond Martial Lemaire Bodo4  \nAbstract  \nBackground High-risk human papillomavirus (HR HPV) infection is the primary cause of cervical cancer, a leading cause of cancer mortality among women in sub-Saharan Africa. In Cameroon, there is a gap in synthetized evidence on HR HPV epidemiology, limiting data-driven prevention strategies. This study provides the first comprehensive national synthesis of HR HPV prevalence, genotype distribution, and HIV co-infection among HPV-positive individuals. Methods A systematic review and meta-analysis were conducted following PRISMA guidelines and registered in PROSPERO (CRD420261282094) . We systematically searched PubMed, Scopus, Web of Science, Embase, Cochrane Library, AJOL and local online publishers. Studies reporting the prevalence of HR HPV among sexually active individuals were included. Pooled prevalence estimates were calculated using random-effects models. Heterogeneity was assessed with I2 statistics and explored through subgroup analyses. The methodological quality of included studies was evaluated using the Joanna Briggs Institute (JBI) critical appraisal tools.  \nResults A total of 33 studies including 18,798 participants were included in this analysis. The overall pooled prevalence of HR HPV was 28 . 95%(95% CI: 19 .74–40. 30; 33 studies; n = 18,798; I2 = 98 . 7%), with a notable decline from 53. 34% before 2014 to 21 .43% in 2021–2023 . Prevalence varied substantially across populations, being highest among women with precancerous or cancerous lesions (90 . 69%; 95% CI: 78.48–96. 30) and female sex workers (62 . 10%; 95% CI: 58 .08–66. 00) compared to women from the general population (21 . 09%; 95% CI: 15.16–28. 55) . Among HPVpositive women, HIV co-infection prevalence was 26 . 17%(95% CI: 13 .48–44. 65, 19 studies; n = 3,589; I2 = 97 . 9%), with higher rates in hospital-based studies (34 . 57%) compared to community-based studies (9 . 18%) . Predominant HR HPV genotypes included HPV16 (28 . 7%), HPV52 (23 . 6%), HPV66 (22 . 9%), HPV33 (22 . 8%), and HPV18 (20 . 2%) . The pooled prevalence of abnormal cervical lesions among HPV-positive women was 35 . 15%(95% CI: 20 .21–53. 70; 12 studies; n = 2,186; I2 = 95 . 2%), including low-grade lesions (34 .4%) and high-grade lesions (19 . 1%) .  \n*Correspondence:  \nFabrice Zobel Lekeumo Cheuyem [zobelcheuyem@gmail.com](zobelcheuyem@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/li","cbCaifcnqnm6onTU","https://ap.wps.com/l/cbCaifcnqnm6onTU","pdf",3170794,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the study objective in Cameroon?\",\"answer\":\"To synthesize national evidence on HR HPV prevalence, genotype distribution, and HIV co-infection among HPV-positive individuals in Cameroon.\"},{\"question\":\"How were studies selected and analyses conducted?\",\"answer\":\"The review followed PRISMA, was registered in PROSPERO, searched multiple databases, included studies reporting HR HPV prevalence among sexually active individuals, and used random-effects models with I² heterogeneity and subgroup analyses.\"},{\"question\":\"What were the key findings on HR HPV prevalence and genotype patterns?\",\"answer\":\"The overall pooled HR HPV prevalence was 28.95%, with higher values in women with precancerous/cancerous lesions and female sex workers. Predominant genotypes included HPV16, HPV52, HPV66, HPV33, and HPV18.\"}]","Prevalence of high-risk human papillomavirus genotypes and associated HIV co-infection in Cameroon - a systematic review and meta-analysis | PDF",1790057565,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b36801dd4a513ac4ffea6aa53ded47e.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cd25d8bef5e76ce4552843d1ece4a33.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fe94228fce84620e3f5151a4d89f7a0.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d2844556d73e793fadaaa39a373f00a.webp",980,1306]